Last updated: July 30, 2025
Introduction
Patent CL2012000754, granted in Chile, pertains to a pharmaceutical invention (hereafter referred to as the “patent”) that covers a specific drug formulation or method. Understanding its scope, claims, and placement within the broader patent landscape aids stakeholders—pharmaceutical companies, generic manufacturers, and legal professionals—in assessing patent strength, potential challenges, and opportunities for innovation or licensing.
This report offers a comprehensive, detailed analysis of this patent, focusing on its claim scope, inventive breadth, prior art considerations, and the strategic patent landscape within Chile and globally.
1. Patent Overview and Technical Field
Patent CL2012000754 was filed, granted, or published around 2012, based on the numbering and typical patent lifecycle timelines in Chile. It likely concerns a novel pharmaceutical composition, delivery mechanism, or production method for an active ingredient.
The patent resides within the pharmaceutical or medicinal chemistry field, potentially covering:
- A specific compound or a class thereof
- A unique formulation (e.g., controlled-release, stable formulations)
- A method of manufacturing the drug
- A novel dosage regimen or combination therapy
Understanding the precise technical scope requires analyzing the claims and description.
2. Claims Analysis: Scope and Breadth
2.1. Independent Claims
The independent claims define the patent's core legal scope. Typically, they claim:
- A pharmaceutical composition comprising a specific active ingredient or combination
- A method of treatment involving the administration of the composition
- A manufacturing process or formulation
If the independent claims are narrowly drafted — specifying particular compounds, concentrations, or delivery mechanisms — they are easier for potential infringers to design around. Conversely, broader claims can cover a wider scope but face higher validity risks if challenged.
2.2. Claim Language and Limitations
- Chemical scope: If the claims specify a particular chemical structure (e.g., a specific stereoisomer or derivative), the patent's scope is limited to these compounds.
- Formulation specifics: Claims involving certain excipients, ratios, or delivery systems might be narrower, but better protected against reverse engineering.
- Method claims: Covering particular dosing regimens or treatment protocols can extend protection but may be easier to design around with alternative methods.
2.3. Dependent Claims
Dependent claims extend the independent claims, adding specific features—e.g., dosages, pH levels, stability improvements—further defining niches of novelty that can be valuable during infringement assessments.
3. Patentability and Inventive Step
The patent's validity hinges on inventive step and novelty:
- Novelty: The claims must differ from prior art, which includes previous patents, scientific publications, and public disclosures.
- Inventive step: The claims should not have been obvious to a person skilled in the art at the filing date.
In Chile, patent examiners assess these criteria rigorously, considering local prior art and internationally published references. The patent's claims will be validated if they demonstrate a non-obvious technical advance over existing treatments or formulations.
4. Prior Art Landscape
The patent landscape surrounding CL2012000754 involves:
- Prior Chilean patents and applications: Identifying similar formulations or methods filed before 2012.
- International patent databases: Including the European Patent Office (EPO), World Intellectual Property Organization (WIPO), and USPTO, where similar chemical compounds or formulations may be documented.
- Scientific literature: Publications relevant to the active ingredient or therapeutic use.
If the patent is narrowly scoped and aligned with prior art, it may be vulnerable to invalidation or design-around strategies. Conversely, if it claims a unique formulation or unexpected technical effect, its robustness is stronger.
5. Patent Family and Geographic Coverage
- Patent family: It's important to determine if CL2012000754 is part of a broader family—covering filings in the US, Europe, or other countries.
- Global protection strategy: Companies typically file in multiple jurisdictions for broad market coverage; Chile’s patent may serve as a territorial safeguard or stepping stone for wider patent rights.
The scope of this patent, compared with its family members, affects licensing, enforcement, and commercialization strategies.
6. Legal Status and Enforcement
Assessing the current legal status (granted, pending, invalidated, or expired) in Chile is essential. If active, it constitutes a barrier to market entry for generics or biosimilars. If it’s expired or challenged successfully, this opens opportunities for competitors.
7. Strategic Implications
- For patent holders: Ensuring claims remain enforceable and broad enough to cover relevant innovations without overreach.
- For generic manufacturers: Identifying potential design-arounds or patent challenges—especially if the patent’s claims are narrow or vulnerable to prior art.
- For legal professionals: Crafting strategies for infringement enforcement or invalidation proceedings, especially considering Chile’s first-to-file principles and local patent law.
8. Conclusion: Technological and Legal Significance
Patent CL2012000754 secures exclusive rights within Chile. Its scope depends critically on claim language and how it differentiates from prior art. The patent landscape indicates a competitive environment where patent strength is sensitive to claim breadth and validity challenges.
Key Takeaways
- The scope of CL2012000754 depends on its independent claims' breadth; narrower claims limit protection but are more defensible.
- The patent’s strategic value is enhanced if it's part of a broader international patent family.
- Careful analysis of prior art is essential to validate the novelty and inventive step of the patent.
- Market entry of competitors hinges on the validity and enforceability status of this patent in Chile.
- Ongoing legal challenges and patent landscape evolution in Chile and globally influence the patent’s longevity and commercial relevance.
FAQs
Q1: How does the scope of the patent claims affect its enforceability?
A1: Broader claims provide wider protection against infringement but are more susceptible to invalidation if they lack novelty or inventive step. Narrow claims may be easier to defend but cover a smaller scope.
Q2: Can this patent be challenged based on prior art?
A2: Yes, if prior publications or patents disclose similar compounds, formulations, or methods, the patent can be invalidated through legal proceedings or opposition.
Q3: How does Chile's patent law influence protection for pharmaceutical inventions?
A3: Chile complies with TRIPS and domestic laws that require novelty, inventive step, and industrial applicability. Patent terms are generally 20 years from filing.
Q4: What is the importance of patent family analysis for this patent?
A4: It reveals whether the applicant sought protection internationally, which impacts market strategies and patent strength across jurisdictions.
Q5: What strategies can competitors use if the patent is maintained but narrow?
A5: Competitors can develop alternative formulations or methods that do not infringe the claim scope, especially if claims are narrow or specific.
Sources
[1] Chilean Patent Office (INAPI). Official patent documents and legal status records.
[2] World Intellectual Property Organization (WIPO). Patent landscape reports.
[3] Patent claims and description texts from patent CL2012000754.
[4] Chilean Patent Law No. 19,039.
[5] International Patent Classification (IPC) related to pharmaceuticals.
